Results 171 to 180 of about 531,165 (296)

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

IL-18-Mediated Tumor Immune Evasion. [PDF]

Curr Issues Mol Biol
Li S, Gao C, Zhao H, Wang D, Liu S.
europepmc   +1 more source

Porous Hybrid Soft Actuators From Liquid Crystal Networks and Lyotropic Chromonic Liquid Crystal Templated Hydrogels

Advanced Materials, EarlyView.
The graphic illustrates the design of a hybrid bilayer composed of a liquid crystal hydrogel (LCH) and a liquid crystal network (LCN). The figure highlights the magnetic alignment of the chromonic hydrogel and the thermal‐responsive actuation of the LCN along with the LCH when both layers are aligned or misaligned, enabling programmable, light‐driven ...
Ramón Santiago Herrera Restrepo, Irving Hafed Tejedor García, Matthew Gene Scarfo, Negin Bouzari, Negar Rajabi, Olga Bantysh, Joel Torres‐Andrés, Christopher W. V. James, Maria Guix, Amirreza Aghakhani, Jordi Ignés‐Mullol, Salvador Pané, Josep Puigmartí‐Luis, Hamed Shahsavan   +13 more
wiley   +1 more source

T-Cell Immunity and Lung Cancer. [PDF]

Respirology
Yamada K, Togashi Y.
europepmc   +1 more source

Remote‐Controllable Immune‐Priming Spot Formation Via Nanocomplexed Hydrogel‐Assisted Histotripsy: Immunoasis

Advanced Materials, EarlyView.
A novel immunotherapeutic strategy combines injectable, adjuvant‐loaded hydrogels with externally controlled histotripsy to create immune‐priming sites within tumors. This approach generates millimeter‐sized immune‐activated lesions with flexible, patient‐tailored treatment scheduling, enabling precise immune activation through tumor ablation‐mediated ...
Sung Hoon Kim, Wonseok Choi, Yurim Kim, Hyeongmin Kim, Gu Won Jeong, Hyewon Park, Inchan Youn, Yoon Park, Sungmin Han, Young‐Min Kim   +9 more
wiley   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

Cancer Discovery, 2017
Jiehui Deng, Jiehui Deng, Eric S. Wang, R. Jenkins, Shuai Li, Ruben Dries, Kathleen B. Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, A. Aref, E. Ivanova, C. Paweletz, M. Bowden, C. Zhou, G. Herter-Sprie, J. Sorrentino, J. Bisi, P. Lizotte, Ashley A. Merlino, Max M. Quinn, Lauren E. Bufe, A. Yang, Yanxi Zhang, Hua Zhang, P. Gao, Ting Chen, Megan E. Cavanaugh, Amanda J. Rode, Eric Haines, P. Roberts, J. Strum, W. Richards, J. Lorch, S. Parangi, Viswanath Gunda, G. Boland, R. Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Gordon J. Freeman, J. Ritz, W. Haining, N. Sharpless, H. Arthanari, Geoffrey I. Shapiro, Geoffrey I. Shapiro, D. Barbie, D. Barbie, N. Gray, Kwok-kin Wong   +50 more
semanticscholar   +1 more source

Fabrication, Properties, and Applications of Scaffolds for Bone Tissue Regeneration

Advanced Materials Technologies, EarlyView.
This review explores cutting‐edge biomaterials and fabrication techniques for scaffolds in bone tissue regeneration. It conducts a critical comparison of various strategies, meticulously analyzes the key contradictions in the field, and outlines an integrated development path spanning from biomaterial selection to clinical application, while ...
Shangsi Chen, Min Wang
wiley   +1 more source

Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges. [PDF]

J Cancer Res Clin Oncol
Zhou H, Shi Y, Wang Y, Bai G.
europepmc   +1 more source

Antitumor activity of thalidomide in refractory multiple myeloma.

New England Journal of Medicine, 1999
S. Singhal, J. Mehta, R. Desikan, D. Ayers, P. Roberson, Paul Eddlemon, N. Munshi, E. Anaissie, C. Wilson, M. Dhodapkar, J. Zeldis, D. Siegel, J. Crowley, B. Barlogie   +13 more
semanticscholar   +1 more source